Quantcast

Latest Pharmaceutical drug Stories

2014-03-28 12:21:55

DUBLIN, Mar. 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/cvsjq3/investigation ) has announced the addition of the "Investigation Report on China Pemetrexed Market, 2009-2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Pemetrexed, originally developed by Eli Lilly and Company, is a multi-targeted antimetabolite antitumor drug. This product is with huge growth potential in the market. Approved by FDA...

2014-03-27 12:30:06

Universal Healthcare Coverage and an Expansion of Benefit Packages will Stimulate Pharmaceutical Sales, According to Findings from Decision Resources Group BURLINGTON, Mass., March 27, 2014 /PRNewswire/ -- Decision Resources Group finds that the size of the Philippine pharmaceutical market (approximately US $3.2 billion) is expected to expand rapidly following the government's enactment of universal healthcare coverage in 2013. As access to affordable medicines improved following prior...

2014-03-26 23:31:29

National network of attorneys continues to offer no-cost consultations to consumers over allegations that Lipitor and other statins increase the risk of developing diabetes. San Diego, CA (PRWEB) March 26, 2014 http://www.resource4thepeople.com/defectivedrugs/lipitor-lawsuit.html Resource4thePeople today announced an important legal update for consumers who are interested in litigation involving allegations that the anti-cholesterol medication Lipitor may cause patients to develop...

2014-03-26 08:28:48

DUBLIN, Mar. 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5bf97k/research_report ) has announced the addition of the "Concise Analysis of the Chinese Antidiabetic Drug Market" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) As China's society is further aging and obesity caused by improved living level and unhealthy lifestyle is increasing, the prevention and cure to diabetes become more difficult. The...

2014-03-26 00:22:04

Series A co-led by 5AM Ventures and Lundbeckfond Ventures LEXINGTON, Mass., March 26, 2014 /PRNewswire/ -- scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today that it has closed a $16.0 million Series A venture financing round co-led by 5AM Ventures and Lundbeckfond Ventures. Proceeds from the financing will be used to further develop its first two pharmaceutical products and...

2014-03-25 23:03:54

The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statins. New York, New York (PRWEB) March 25, 2014 Hundreds of Lipitor lawsuits (http://www.thelipitorlawsuit.com/) that allege use of the statin drug caused patients to develop new-onset Type 2 diabetes have begun to move forward in a multidistrict litigation underway in U.S. District Court, District of South Carolina. According to an Order...

2014-03-25 23:02:29

Federal litigation involving Pfizer's cholesterol-lowering drug Lipitor has been consolidated before a single judge in South Carolina. (PRWEB) March 25, 2014 The law firm McSweeney / Langevin continues to advise women regarding potential legal claims regarding a possible link between use of Lipitor and the development of type 2 diabetes. Recently, federal litigation involving Pfizer, and plaintiffs alleging Lipitor caused type 2 diabetes, was centralized in South Carolina following...

2014-03-24 23:03:35

GIA announces the release of a comprehensive global report on Personalized Medicines markets. Global market for Personalized Medicines is projected to reach US$200 billion by 2020, driven by aging population, escalating healthcare costs, growing focus on improving patient outcomes and the ensuing need for more effective therapies and treatment options. San Jose, CA (PRWEB) March 24, 2014 Follow us on LinkedIn -Conventional trial and error treatment method based mass prescription...

2014-03-24 20:23:39

DUBLIN, March 24, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/zkjlpz/investigation) has announced the addition of the "Investigation Report on China Atorvastatin Market, 2009-2018" [http://www.researchandmarkets.com/research/zkjlpz/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The prevalence rate of abnormal blood lipid in China is lower than that in most developed...

2014-03-22 12:21:28

DALLAS, March 22, 2014 /PRNewswire/ -- ReportsnReports.com offers "Global Orphan Drug Market Outlook 2018", "Global Orphan Drugs Market 2014-2018" and "Global Orphan Drug Pipeline Analysis" research reports in its store. The returns on investment from orphan drugs are expected to help the pharma companies to overcome the impact of revenue loss due to expiry of patents of blockbuster drugs. The major drivers for companies to increasingly invest in orphan drugs include...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related